Click here to search courses using NAPNAP's previous Course Catalog layout.

Title
Category
Credits
Event date
Cost
  • Primary Care
  • Acute Care
  • FREE for Members
  • Human Trafficking
  • 1.50 Contact hours
$0.00
This course is not accredited by NAPNAP. This course is approved by Texas Health and Human Services to meet the requirements of H.B. 2059. Providers must register for a free PedsCE account, and be logged in to watch the webinar and receive the certificate. This course was created in collaboration with Partners for Vulnerable Youth.
  • Acute Care
  • 0.50 Contact hours
$10.00
0.5 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $ 5.00 for NAPNAP Members. For non-members, this continuing education activity rate is $10. Caring for a child on chronic ventilation can be challenging. An overview of chronic ventilation and care of the child will be discussed so providers who do not care for these children on regular basis will have a baseline understanding of these patients.
  • Acute Care
  • 0.75 Contact hours
$15.00
0.75 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $ 7.50 for NAPNAP Members. For non-members, this continuing education activity rate is $15. Pediatric diabetes care is ever-evolving, and novel medications and technologies introduced to the market are transforming patient outcomes. This course will cover case studies in critical sedation and analgesia.
  • Acute Care
  • FREE for Members
  • Infectious Disease
  • 0.75 Contact hours
$0.00
0.75 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and for non- members.
  • Primary Care
  • Acute Care
  • Mental Health
  • Pharmacology CE
  • Psychopharmacology CE
$555.00
You get 26 courses from NAPNAP's 2023 National Conference totaling 29 NAPNAP Contact Hours, 7.75 Pharmacology and 0.5 Psychopharmacology. This continuing education activity is offered at a member-only discounted rate of $199, a cost-savings of more than $65. Non-members may purchase this bundle for $555. Join NAPNAP before purchasing to save more than $350.
  • Acute Care
  • FREE for Members
  • Infectious Disease
  • Pharmacology CE
  • 1.00 Contact hours
$0.00
1.0 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and for non- members. Lyme disease is the most common vector-borne disease in the United States, with approximately 476,000 people diagnosed and treated each year. Many patients with undiagnosed and untreated early Lyme disease will progress to disseminated Lyme disease. Disseminated Lyme disease is often treated in the acute care setting and may be difficult for providers to identify without the classic erythema migrans rash of early localized Lyme disease. This webinar will review presentations of disseminated Lyme disease in pediatric patients as well as appropriate diagnostics and treatment plans utilizing the 2020 Lyme disease guidelines.
  • Primary Care
  • Acute Care
  • Human Trafficking
  • 1.00 Contact hours
$20.00
1.0 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate of $10 to NAPNAP Members. For non-members, this continuing education activity rate is $20. This course is intended to help health care providers understand the nature of human trafficking with a focus on the pediatric population. In Module 101 of the 3-PARRT series, we will review the definition of trafficking, explore myths and facts, sensationalism, and statistics, as well as the legal foundation and history of human trafficking in the United States. We will also discuss theoretical constructs related to trafficking, what a trafficker is, how trafficking happens, risks and vulnerabilities, underserved populations, and the health consequences of trafficking.
  • Primary Care
  • Acute Care
  • Human Trafficking
  • 0.50 Contact hours
$10.00
0.5 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate of $5 to NAPNAP Members. For non-members, this continuing education activity rate is $10. This course is intended to help health care providers understand the nature of human trafficking with a focus on the pediatric population. Module 102 of the 3-PARRT series reviews the encounter of the trafficked or potentially trafficked patient in the clinical environment. We will discuss patient/provider barriers, how to approach the trafficked patient, history taking, review of systems, and physical assessment. We'll also go over maintaining safety for all involved, proper documentation of the encounter, and trauma informed care.
  • Primary Care
  • Acute Care
  • Human Trafficking
  • 1.00 Contact hours
$20.00
1.0 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate of $10 to NAPNAP Members. For non-members, this continuing education activity rate is $20. This course is intended to help health care providers understand the nature of human trafficking with a focus on the pediatric population. In Module 103 of the 3-PARRT series we will discuss how to respond to a patient who is being or may be trafficked, resources and referrals to make, vicarious trauma, and consideration for supporting the patient longitudinally. We'll also discuss the importance of institutional policies and procedures, how to develop them, stakeholder intersections, and the work NAPNAP has done in helping develop the core competencies.
  • Primary Care
  • Acute Care
  • Pharmacology
  • 1.00 Contact hours
$20.00
1.0 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. Current pediatric prescribing recommendations will be reviewed. An extensive review and update will provide the participant with an improved understanding of therapeutic benefits as well as potential risks of medications prescribed for children, including efficacy, safety and prescribing recommendations. Current MedWatch Safety Alerts issued by the FDA will also be covered.

Pages